Oncotarget

Research Papers:

This article has been retracted. Retraction in: Oncotarget. 2019; 10:5730-5730.

PATZ1 induces PP4R2 to form a negative feedback loop on IKK/NF-κB signaling in lung cancer

Ming-Yi Ho, Chi-Ming Liang _ and Shu-Mei Liang

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:52255-52269. https://doi.org/10.18632/oncotarget.10427

Metrics: PDF 2669 views  |   HTML 2837 views  |   ?  


Abstract

Ming-Yi Ho1, Chi-Ming Liang1, Shu-Mei Liang1,2

1Genomics Research Center, Academia Sinica, Taipei 11529, Taiwan, ROC

2Agricultural Biotechnology Research Center, Academia Sinica, Taipei 11529, Taiwan, ROC

Correspondence to:

Chi-Ming Liang, email: [email protected]

Shu-Mei Liang, email: [email protected]

Keywords: epithelial-mesenchymal transition (EMT), IκB kinase (IKK), migration/invasion/metastasis, PATZ1, protein phosphatase 4 (PP4)

Received: February 29, 2016     Accepted: June 17, 2016     Published: July 6, 2016

ABSTRACT

Activation of IKK enhances NF-κB signaling to facilitate cancer cell migration, invasion and metastasis. Here, we uncover the existence of a negative feedback loop of IKK. The transcription factor PATZ1 induces protein phosphatase-4 (PP4) regulatory subunit 2 (PP4R2) in an IKK-dependent manner. PP4R2 enhances the binding of PP4 to phosphorylated IKK to inactivate IKK/NF-κB signaling during sustained stimulation by cellular stimuli such as growth factors and inflammatory mediators. Matched pair studies reveal that primary lung cancers express more PATZ1 and PP4R2 than lymph node metastases in patients. Ectopic PATZ1 decreases invasion/colonization of lung cancers and prolongs the survival of xenograft mice. These effects of PATZ1 are reversed by downregulating PP4R2. Our results suggest that PATZ1 and PP4R2 provide negative feedback on IKK/NF-κB signaling to prevent cancer cells from over-stimulation from cellular stimuli; a decline in PATZ1 and PP4R2 is functionally associated with cancer migration/invasion and agents enhancing PATZ1 and PP4R2 are worth exploring to prevent invasion/metastasis of lung cancers.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10427